News & Updates
Showing Psychiatry articles
Showing

EULAST: No clear benefits in prescribing long-acting over oral antipsychotics for early-phase schizophrenia
Long-acting injectable antipsychotics (LAIAs) showed no substantial advantage over oral antipsychotics in terms of time to discontinuation in patients with early-phase schizophrenia, the EULAST trial has demonstrated.

Antipsychotic prescriptions for dementia soared during COVID-19 pandemic
The overall rate of antipsychotic drug prescriptions to patients with dementia increased markedly during the initial months of the COVID-19 pandemic, and did not return to prepandemic levels when the acute phase was over, a multinational network cohort study has shown.

Behavioural therapy may improve physical activity, sleep quality in asthma patients
Individuals with asthma may benefit from a behavioural intervention to increase their physical activity (PA), which may lead to improvements in quality of life and sleep, as well as a reduction in asthma and anxiety symptoms, suggest the results of a recent study.

CVD, mood disorders up risk of dementia in RA patients
Among patients with rheumatoid arthritis (RA), those with clinically active RA, cardiovascular or cerebrovascular disease (CVD), hypertension, depression, and anxiety are at greater risk of dementia, reveals a study. Among CVD events, ischaemic stroke and heart failure are significantly associated with an increased dementia risk.

Smartphone app supports self-management strategies for bipolar disorder
A smartphone-based self-management intervention may reduce relapse risk and manic symptom severity for patients with bipolar disorder in asymptomatic recovery, a randomized clinical trial has shown.




